Other and unspecified reactive psychosis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of atypical psychosis.
|
24132900 |
2013 |
Psychotic Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association study of atypical psychosis.
|
24132900 |
2013 |
Narcolepsy
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association database developed in the Japanese Integrated Database Project.
|
19629137 |
2009 |
Myasthenia Gravis
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was a decrease in thymocyte miR-653 and an increase in TRIM9 in thymic tissues of MG mice. miR-653 was found to negatively regulate TRIM9.
|
30703767 |
2019 |
Stress, Psychological
|
0.010 |
Biomarker
|
disease |
BEFREE |
We therefore examined the contribution of childhood adversity through pregnancy and the first year of life to hair and salivary cortisol measures of early life stress in the India SPRING home visits cluster RCT which aims to improve early childhood development.
|
31174162 |
2019 |
Gestational Diabetes
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-Blind Randomized Controlled Trial.
|
30659070 |
2019 |
Paraneoplastic Cerebellar Degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
|
30350014 |
2019 |
Ischemic stroke
|
0.010 |
Biomarker
|
disease |
BEFREE |
TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice.
|
30970257 |
2019 |
PREMATURE CENTROMERE DIVISION
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-TRIM9 and anti-TRIM67 Abs appeared to be specific biomarkers of PCD and should be added to the panel of antigens tested when this is suspected.
|
30350014 |
2019 |
Primary Ciliary Dyskinesia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-TRIM9 and anti-TRIM67 Abs appeared to be specific biomarkers of PCD and should be added to the panel of antigens tested when this is suspected.
|
30350014 |
2019 |
Bone Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
We externally validated the 2008-SPRING and the 2013-SPRING models in a prospective cohort (n = 164) of patients who underwent surgery for metastatic bone disease in the extremities from May 2014 to May 2016, called the validation cohort.
|
30020148 |
2018 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients.
|
29669288 |
2018 |
Secondary malignant neoplasm of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
We produced the 2013-SPRING model by adding to the 2008-SPRING model (n = 130) a cohort of patients from a consecutive institutional database of patients who underwent surgery for bone metastases in the extremities with bone resection and reconstruction between 2009 and 2013 at a highly specialized surgical center in Denmark (n = 140).
|
30020148 |
2018 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients.
|
29669288 |
2018 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients.
|
29669288 |
2018 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients.
|
29669288 |
2018 |
Respiratory Syncytial Virus Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
The model considered the most recent evidence from Spanish observational and epidemiological studies on RSV infection: the FLIP II study provided hospital admission and Intensive Care Unit (ICU) admission rates; in-hospital mortality rate was drawn from an epidemiological study from 2004 to 2012; recurrent wheezing rates associated to RSV infection from SPRING study were adjusted by the evidence on the palivizumab effect from clinical trials.
|
29041909 |
2017 |
Wheezing
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The model considered the most recent evidence from Spanish observational and epidemiological studies on RSV infection: the FLIP II study provided hospital admission and Intensive Care Unit (ICU) admission rates; in-hospital mortality rate was drawn from an epidemiological study from 2004 to 2012; recurrent wheezing rates associated to RSV infection from SPRING study were adjusted by the evidence on the palivizumab effect from clinical trials.
|
29041909 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In an effort to profile the expression patterns of TRIM superfamily in several non-small cell lung cancer (NSCLC) cell lines, we found that the expression of 10 TRIM genes including TRIM3, TRIM7, TRIM14, TRIM16, TRIM21, TRIM22, TRIM29, TRIM59, TRIM66 and TRIM70 was significantly upregulated in NSCLC cell lines compared with the normal human bronchial epithelial (HBE) cell line, whereas the expression of 7 other TRIM genes including TRIM4, TRIM9, TRIM36, TRIM46, TRIM54, TRIM67 and TRIM76 was significantly down-regulated in NSCLC cell lines compared with that in HBE cells.
|
26599082 |
2015 |
HIV-1 infection
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
|
24074642 |
2013 |
Parkinson Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical examination revealed that TRIM9 is localized to the neurons in the normal mouse and human brain and that TRIM9 immunoreactivity is severely decreased in the affected brain areas in Parkinson's disease and dementia with Lewy bodies.
|
20085810 |
2010 |
Lewy Body Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggest that TRIM9 plays an important role in the regulation of neuronal functions and participates in pathological process of Lewy body disease through its ligase activity.
|
20085810 |
2010 |
Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These genes (ACY1, WT1, SELENBP1, COBL, EFHD1, AGXT2L1, ALDH5A1, THEM2, ABCB1, FLJ14146, CSPG2, TRIM9 and HEY1) are good candidates for genes whose activity is changed upon the decrease of HNF4alpha in RCC.
|
16007190 |
2005 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These genes (ACY1, WT1, SELENBP1, COBL, EFHD1, AGXT2L1, ALDH5A1, THEM2, ABCB1, FLJ14146, CSPG2, TRIM9 and HEY1) are good candidates for genes whose activity is changed upon the decrease of HNF4alpha in RCC.
|
16007190 |
2005 |